← BioNTech SE BNTX
Market Price
$93.08
Market Cap
$23.29B
P/E Ratio
N/A
Revenue (FY 2025)
↑4.3% YoY
$2.87B
3-Yr CAGR: -45.1%
Net Income
↓-70.8% YoY
-$1.14B
Net Margin: -39.6%
Free Cash Flow
↓-14.1% YoY
$161.90M
FCF Yield: 0.70%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
-5.9%
ROA: -5.2%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (BNTX)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2017 | $61.6M | — | $52.3M | $-85.7M | — | — | — | $-0.7M | $-25.0M | — |
| FY 2018 | $127.6M | +107.1% | $113.9M | $-0.2M | +99.7% | — | — | $2.0M | $-27.9M | -11.4% |
| FY 2019 | $108.6M | -14.9% | $91.2M | $-0.1M | +52.3% | — | — | $1.3M | $-37.3M | -33.8% |
| FY 2020 | $482.3M | +344.2% | $423.0M | $15.2M | +13,201.7% | — | — | $1.4M | $-64.6M | -73.0% |
| FY 2021 | $18,976.7M | +3,834.4% | $16,065.2M | — | -100.0% | — | — | $1.2M | $-126.3M | -95.5% |
| FY 2022 | $17,310.6M | -8.8% | $14,315.6M | $9,434.4M | — | — | — | $29.3M | $-299.9M | -137.5% |
| FY 2023 | $3,819.0M | -77.9% | $3,219.2M | $930.3M | -90.1% | — | — | $258.2M | $8.8M | +102.9% |
| FY 2024 | $2,751.1M | -28.0% | $2,209.8M | $-665.3M | -171.5% | — | — | $474.9M | $188.4M | +2,040.9% |
| FY 2025 | $2,869.9M | +4.3% | $2,228.1M | $-1,136.1M | -70.8% | — | — | $337.0M | $161.9M | -14.1% |
Valuation
Market Price
$93.08
Market Cap
$23.29B
Enterprise Value
$15.88B
P/E Ratio
N/A
P/B Ratio
1.22
FCF Yield
0.70%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
77.64%
Operating Margin
-48.95%
Net Margin
-39.59%
Return on Equity (ROE)
-5.91%
Return on Assets (ROA)
-5.17%
Asset Turnover
0.13x
Revenue 3-Yr CAGR
-45.06%
Financial Health & Liquidity
Current Ratio
0.80
Cash Ratio
117.00
Debt / Equity
0.014
Debt / Assets
0.012
Cash & Equivalents
$7.68B
Total Debt
$267.40M
Book Value / Share
$76.02
Cash Flow Efficiency
Operating Cash Flow
$337.00M
Capital Expenditures (CapEx)
$175.10M
Free Cash Flow
$161.90M
OCF / Revenue
11.74%
FCF / Revenue
5.64%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$76.02
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$21.99B
Total Liabilities
$2.76B
Stockholders' Equity
$19.22B
Current Assets
$52.60M
Current Liabilities
$65.60M